» Articles » PMID: 6129277

Loss of Stem Cell Repopulating Ability Upon Transplantation. Effects of Donor Age, Cell Number, and Transplantation Procedure

Overview
Journal J Exp Med
Date 1982 Dec 1
PMID 6129277
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Long-term functional capacities of marrow cell lines were defined by competitive repopulation, a technique capable of detecting a small decline in repopulating abilities. There was little or no difference between cells from old and young donors, but a single serial transplantation caused a large decline in repopulating ability. Varying the numbers of marrow cells transplanted into the initial carrier from 10(5) to 10(7) did not alter the ability of the carrier's marrow cells to repopulate in competition with previously untransplanted cells. This ability was improved only in carriers that had received 10(8) marrow cells, although deleterious effects of transplantation were still present. These effects were not solely caused by cell damage from the transplantation procedure, because transplantation by parabiosis, or recovery from sublethal irradiation without transplantation, reduced repopulating abilities as much as transplanting 10(5) to 10(7) marrow cells. The transplantation effect also was not caused solely by irradiation, because the same effect appeared in unirradiated W/Wv carriers. The transplantation effect was more pronounced when donors were identified by hemoglobin type than by chromosome markers, implying that nonerythroid cell lines may be less affected by transplantation than erythroid precursor cells. When the effects of a lifetime of normal function and a single transplantation were compared, the latter caused 3-7 times more decline in repopulating abilities of phytohemagglutinin-responsive cell precursors, and at least 10-20 times more decline in erythroid cell precursors. Stem cell lines can be serially transplanted at least five times before losing their ability to repopulate and save lethally irradiated recipients or to cure genetically anemic mice. Therefore, if transplantation causes an acceleration of the normal aging process, these figures suggest that stem cells should be able to function normally through at least 15-50 life spans.

Citing Articles

Endothelial BMAL1 decline during aging leads to bone loss by destabilizing extracellular fibrillin-1.

Yin Y, Tang Q, Yang J, Gui S, Zhang Y, Shen Y J Clin Invest. 2024; 134(24).

PMID: 39680455 PMC: 11645155. DOI: 10.1172/JCI176660.


DNA fork remodeling proteins, Zranb3 and Smarcal1, are uniquely essential for aging hematopoiesis.

Kushinsky S, Puccetti M, Adams C, Shkundina I, James N, Mahon B Aging Cell. 2024; 23(11):e14281.

PMID: 39044358 PMC: 11561652. DOI: 10.1111/acel.14281.


Young blood-mediated cerebromicrovascular rejuvenation through heterochronic parabiosis: enhancing blood-brain barrier integrity and capillarization in the aged mouse brain.

Gulej R, Nyul-Toth A, Csik B, Patai R, Petersen B, Negri S Geroscience. 2024; 46(5):4415-4442.

PMID: 38727872 PMC: 11336025. DOI: 10.1007/s11357-024-01154-8.


Rejuvenation of cerebromicrovascular function in aged mice through heterochronic parabiosis: insights into neurovascular coupling and the impact of young blood factors.

Gulej R, Nyul-Toth A, Csik B, Petersen B, Faakye J, Negri S Geroscience. 2023; 46(1):327-347.

PMID: 38123890 PMC: 10828280. DOI: 10.1007/s11357-023-01039-2.


Genomic Aging, Clonal Hematopoiesis, and Cardiovascular Disease.

Natarajan P Arterioscler Thromb Vasc Biol. 2022; 43(1):3-14.

PMID: 36353993 PMC: 9780188. DOI: 10.1161/ATVBAHA.122.318181.


References
1.
Barnes D, Ford C, LOUTIT J . [Serial grafts of homologous bone marrow in irradiated mice]. Sang. 1959; 30:762-5. View

2.
Johnson F, Thomas E, CLARK B, Chard R, HARTMANN J, Storb R . A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. N Engl J Med. 1981; 305(15):846-51. DOI: 10.1056/NEJM198110083051502. View

3.
Botnick L, Hannon E, Hellman S . Nature of the hemopoietic stem cell compartment and its proliferative potential. Blood Cells. 1979; 5(2):195-210. View

4.
KALISS N . Jerne plaque assay for antibody-forming spleen cells: some technical modifications. Transplantation. 1971; 12(2):146-7. DOI: 10.1097/00007890-197108000-00009. View

5.
Price G, Makinodan T . Immunologic deficiencies in senescence. II. Characterization of extrinsic deficiencies. J Immunol. 1972; 108(2):413-7. View